Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile
2018 · The Oncologist · 78 citations
https://doi.org/10.1634/theoncologist.2017-0629
H
Helei Hou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
1.7K
Citations
24
h-index
38
i10-index
Helei Hou is an academic researcher from Qingdao University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Gastric Cancer Management and Outcomes & Cancer Genomics and Diagnostics. The author has an h-index of 24, co-authored 106 publications.
ORCID: 0000-0001-8502-7461Papers by this author
worksAdvancement in research and therapy of NF1 mutant malignant tumors
2020 · Cancer Cell International · 48 citations
https://doi.org/10.1186/s12935-020-01570-8
Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancers
2020 · Biomedicine & Pharmacotherapy · 36 citations
https://doi.org/10.1016/j.biopha.2020.110626
Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
2017 · Scientific Reports · 28 citations
https://doi.org/10.1038/s41598-017-14962-0
Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: A single-centre retrospective study
2023 · Translational Oncology · 19 citations
https://doi.org/10.1016/j.tranon.2023.101657
Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
2021 · Scientific Reports · 18 citations
https://doi.org/10.1038/s41598-020-80735-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat